{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:13:43Z","timestamp":1684858423839},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00108-017-0268-2","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T05:42:25Z","timestamp":1496727745000},"page":"675-681","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Individuelle Therapiestrategien bei Clostridium-difficile-Infektionen"],"prefix":"10.1007","volume":"58","author":[{"given":"P.","family":"Solbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"key":"268_CR1","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/AAC.00090-08","volume":"52","author":"WN Al-Nassir","year":"2008","unstructured":"Al-Nassir WN, Sethi AK, Li Y et al (2008) Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 52:2403\u20132406","journal-title":"Antimicrob Agents Chemother"},{"key":"268_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1198-743x.2001.00289.x","volume":"7","author":"F Barbut","year":"2001","unstructured":"Barbut F, Petit JC (2001) Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 7:405\u2013410","journal-title":"Clin Microbiol Infect"},{"key":"268_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","volume":"377","author":"MP Bauer","year":"2011","unstructured":"Bauer MP, Notermans DW, van Benthem BH et al (2011) Clostridium difficile infection in Europe: A\u00a0hospital-based survey. Lancet 377:63\u201373","journal-title":"Lancet"},{"key":"268_CR4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/pgmj.63.745.993","volume":"63","author":"PJ Bingley","year":"1987","unstructured":"Bingley PJ, Harding GM (1987) Clostridium difficile colitis following treatment with metronidazole and vancomycin. Postgrad Med\u00a0J 63:993\u2013994","journal-title":"Postgrad Med J"},{"key":"268_CR5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","volume":"41","author":"G Cammarota","year":"2015","unstructured":"Cammarota G, Masucci L, Ianiro G et\u00a0al (2015) Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 41:835\u2013843","journal-title":"Aliment Pharmacol Ther"},{"key":"268_CR6","volume-title":"Antibiotic\/Antimicrobial Resistance","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention (2015) Antibiotic\/Antimicrobial Resistance. \n                        http:\/\/www.cdc.gov\/drugresistance\/biggest_threats.html"},{"issue":"Suppl 2","key":"268_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cid\/cis462","volume":"55","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Miller MA, Louie TJ et\u00a0al (2012) Treatment of first recurrence of Clostridium difficile infection: Fidaxomicin versus vancomycin. Clin Infect Dis 55(Suppl 2):154\u2013161","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"268_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","volume":"20","author":"SB Debast","year":"2014","unstructured":"Debast SB, Bauer MP, Kuijper EJ et\u00a0al (2014) European society of clinical microbiology and infectious diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 20(Suppl 2):1\u201326","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"268_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","volume":"17","author":"KE Dingle","year":"2017","unstructured":"Dingle KE, Didelot X, Quan TP et al (2017) Effects of control interventions on Clostridium difficile infection in England: An observational study. Lancet Infect Dis 17(4):411\u2013421","journal-title":"Lancet Infect Dis"},{"key":"268_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/655692","volume":"51","author":"LH Gould","year":"2010","unstructured":"Gould LH, Limbago B (2010) Clostridium difficile in food and domestic animals: A\u00a0new foodborne pathogen? Clin Infect Dis 51:577\u2013582","journal-title":"Clin Infect Dis"},{"key":"268_CR11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1055\/s-0030-1251918","volume":"135","author":"T Grunewald","year":"2010","unstructured":"Grunewald T, Kist M, Mutters R et\u00a0al (2010) Clostridium difficile infection. Dtsch Med Wochenschr 135:699\u2013703","journal-title":"Dtsch Med Wochenschr"},{"key":"268_CR12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0034-1399337","volume":"53","author":"S Hagel","year":"2015","unstructured":"Hagel S, Epple HJ, Feurle GE et al (2015) S2k-guideline gastrointestinal infectious diseases and Whipple\u2019s disease. Z\u00a0Gastroenterol 53:418\u2013459","journal-title":"Z Gastroenterol"},{"key":"268_CR13","first-page":"583","volume":"113","author":"S Hagel","year":"2016","unstructured":"Hagel S, Fischer A, Ehlermann P et\u00a0al (2016) Fecal Microbiota transplant in patients with recurrent Clostridium difficile infection. Dtsch Arztebl Int 113:583\u2013589","journal-title":"Dtsch Arztebl Int"},{"key":"268_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/501751","volume":"21","author":"H Hanna","year":"2000","unstructured":"Hanna H, Raad I, Gonzalez V et\u00a0al (2000) Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 21:226\u2013228","journal-title":"Infect Control Hosp Epidemiol"},{"key":"268_CR15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ajic.2012.01.018","volume":"40","author":"M Hell","year":"2012","unstructured":"Hell M, Sickau K, Chmelizek G et\u00a0al (2012) Absence of Clostridium difficile in asymptomatic hospital staff. Am J Infect Control 40:1023\u20131024","journal-title":"Am J Infect Control"},{"key":"268_CR16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/424667","volume":"39","author":"B Hota","year":"2004","unstructured":"Hota B (2004) Contamination, disinfection, and cross-colonization: Are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 39:1182\u20131189","journal-title":"Clin Infect Dis"},{"key":"268_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ajg.2011.398","volume":"107","author":"S Khanna","year":"2012","unstructured":"Khanna S, Pardi DS, Aronson SL et al (2012) The epidemiology of community-acquired Clostridium difficile infection: A\u00a0population-based study. Am J Gastroenterol 107:89\u201395","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 6","key":"268_CR18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2006.01580.x","volume":"12","author":"EJ Kuijper","year":"2006","unstructured":"Kuijper EJ, Coignard B, Tull P et al (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(Suppl 6):2\u201318","journal-title":"Clin Microbiol Infect"},{"key":"268_CR19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","volume":"342","author":"L Kyne","year":"2000","unstructured":"Kyne L, Warny M, Qamar A et\u00a0al (2000) Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N\u00a0Engl J Med 342:390\u2013397","journal-title":"N Engl J Med"},{"key":"268_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.sla.0000236628.79550.e5","volume":"245","author":"F Lamontagne","year":"2007","unstructured":"Lamontagne F, Labbe AC, Haeck O et\u00a0al (2007) Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a\u00a0hypervirulent strain. Ann Surg 245:267\u2013272","journal-title":"Ann Surg"},{"key":"268_CR21","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","volume":"365","author":"VG Loo","year":"2011","unstructured":"Loo VG, Bourgault A\u2011M, Poirier L et al (2011) Host and pathogen factors for Clostridium difficile infection and colonization. New Engl J Med 365:1693\u20131703","journal-title":"New Engl J Med"},{"key":"268_CR22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie TJ, Miller MA, Mullane KM et\u00a0al (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N\u00a0Engl J Med 364:422\u2013431","journal-title":"N Engl J Med"},{"key":"268_CR23","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1128\/AAC.00504-15","volume":"59","author":"T Louie","year":"2015","unstructured":"Louie T, Nord CE, Talbot GH et al (2015) Multicenter, double-blind, randomized, phase 2 study evaluating the novel antibiotic Cadazolid in patients with Clostridium difficile infection. Antimicrob Agents Chemother 59:6266\u20136273","journal-title":"Antimicrob Agents Chemother"},{"key":"268_CR24","first-page":"723","volume":"111","author":"C Lubbert","year":"2014","unstructured":"Lubbert C, John E, von Muller L (2014) Clostridium difficile infection: Guideline-based diagnosis and treatment. Dtsch Arztebl Int 111:723\u2013731","journal-title":"Dtsch Arztebl Int"},{"key":"268_CR25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamainternmed.2015.42","volume":"175","author":"EG McDonald","year":"2015","unstructured":"McDonald EG, Milligan J, Frenette C et\u00a0al (2015) Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med 175:784\u2013791","journal-title":"JAMA Intern Med"},{"key":"268_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/13543784.2016.1161025","volume":"25","author":"LV McFarland","year":"2016","unstructured":"McFarland LV (2016) Therapies on the horizon for Clostridium difficile infections. Expert Opin Investig Drugs 25:541\u2013555","journal-title":"Expert Opin Investig Drugs"},{"key":"268_CR27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00103-012-1556-6","volume":"55","author":"L Muller von","year":"2012","unstructured":"von Muller L, Halfmann A, Herrmann M (2012) Current data and trends on the development of antibiotic resistance of Clostridium difficile. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55:1410\u20131417","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"268_CR28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E Nood van","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M et\u00a0al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N\u00a0Engl J Med 368:407\u2013415","journal-title":"N Engl J Med"},{"key":"268_CR29","volume-title":"Clostridium difficile","author":"Robert Koch Institut","year":"2016","unstructured":"Robert Koch Institut (2016) Clostridium difficile. \n                        https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Clostridium.html"},{"key":"268_CR30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cid\/civ409","volume":"61","author":"KE Rokas","year":"2015","unstructured":"Rokas KE, Johnson JW, Beardsley JR et\u00a0al (2015) The addition of intravenous Metronidazole to oral Vancomycin is associated with improved mortality in critically ill patients with Clostridium difficile infection. Clin Infect Dis 61:934\u2013941","journal-title":"Clin Infect Dis"},{"key":"268_CR31","first-page":"167","volume-title":"Mikrobiom Wissenstand und Perspektiven","author":"P Solbach","year":"2016","unstructured":"Solbach P, Bachmann O (2016) Clostridium difficile und andere gastrointestinale Infektionen. In: Stallmach A, Vehreschild M (Hrsg) Mikrobiom Wissenstand und Perspektiven, S\u00a0167\u2013189 (Kapitel\u00a012)"},{"key":"268_CR32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00108-016-0149-0","volume":"57","author":"A Stallmach","year":"2016","unstructured":"Stallmach A (2016) Clostridium difficile infection: What is currently available for treatment? Internist (Berl) 57:1182\u20131190","journal-title":"Internist (Berl)"},{"issue":"19","key":"268_CR33","first-page":"345","volume":"112","author":"J Stausberg","year":"2015","unstructured":"Stausberg J (2015) Epidemiologie der Clostridium-difficile-Infektion. Dtsch Arztebl Int 112(19):345","journal-title":"Dtsch Arztebl Int"},{"key":"268_CR34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","volume":"108","author":"CM Surawicz","year":"2013","unstructured":"Surawicz CM, Brandt LJ, Binion DG et\u00a0al (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108:478\u2013498 (quiz 499)","journal-title":"Am J Gastroenterol"},{"key":"268_CR35","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1099\/mic.0.042010-0","volume":"156","author":"GW Tannock","year":"2010","unstructured":"Tannock GW, Munro K, Taylor C et al (2010) A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology 156:3354\u20133359","journal-title":"Microbiology"},{"key":"268_CR36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cid\/cir830","volume":"54","author":"AA Venugopal","year":"2012","unstructured":"Venugopal AA, Johnson S (2012) Fidaxomicin: A\u00a0novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection. Clin Infect Dis 54:568\u2013574","journal-title":"Clin Infect Dis"},{"key":"268_CR37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","volume":"376","author":"MH Wilcox","year":"2017","unstructured":"Wilcox MH, Gerding DN, Poxton IR et\u00a0al (2017) Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N\u00a0Engl J Med 376:305\u2013317","journal-title":"N Engl J Med"},{"key":"268_CR38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ajg.2015.22","volume":"110","author":"IM Zacharioudakis","year":"2015","unstructured":"Zacharioudakis IM, Zervou FN, Pliakos EE et al (2015) Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: A\u00a0systematic review and meta-analysis. Am J Gastroenterol 110:381\u2013390 (quiz 391)","journal-title":"Am J Gastroenterol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-017-0268-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0268-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0268-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T06:38:06Z","timestamp":1498545486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-017-0268-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s00108-017-0268-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,6]]}}}